AstraZeneca (LSE:AZN) recently announced promising clinical trial results for ENHERTU, which may reflect its ongoing commitment to enhancing therapeutic options for HER2-positive metastatic breast ...

Phenomenex Inc., a Danaher Company, a global leader in the research and manufacture of advanced technologies for the separation sciences, has announced the expansion of its product portfolio at ASMS ...

Dr. Tasso Milliotis, Principal Scientist at AstraZeneca, has already experienced ... operating company within the Life Sciences group of Danaher Corporation.

Last week, readers were most interested in a story about what's up Roche's sleeve as it talked about its plans during its investor day.

Blood test-guided treatment with AstraZeneca pill cut risk of breast cancer progression, study finds Treating breast cancer patients with AstraZeneca's experimental pill camizestrant at the first ...

May 30, 2025 AstraZeneca agrees to $51 million settlement in Seroquel antitrust class action Drugmaker AstraZeneca has agreed to pay $50.9 million to settle a class action lawsuit in U.S. court ...

Visit a quote page and your recently viewed tickers will be displayed here.